| scholarly article | Q13442814 |
| P50 | author | Uwe Himmelreich | Q47494676 |
| Guilhem Janbon | Q55154887 | ||
| P2093 | author name string | Kyung J Kwon-Chung | |
| Yun C Chang | |||
| Frédérique Moyrand | |||
| P2860 | cites work | Comparison of the genomes of two Xanthomonas pathogens with differing host specificities | Q22122346 |
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| A comprehensive set of sequence analysis programs for the VAX | Q26778432 | ||
| Members of the evolutionarily conserved PMT family of protein O-mannosyltransferases form distinct protein complexes among themselves | Q27932724 | ||
| Multi-protein complexes in the cis Golgi of Saccharomyces cerevisiae with alpha-1,6-mannosyltransferase activity | Q27935634 | ||
| The KTR and MNN1 mannosyltransferase families of Saccharomyces cerevisiae | Q27936708 | ||
| The Saccharomyces cerevisiae protein Mnn10p/Bed1p is a subunit of a Golgi mannosyltransferase complex | Q27938715 | ||
| The oligosaccharyltransferase complex from yeast | Q28293042 | ||
| Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. | Q30769905 | ||
| Mating-type locus of Cryptococcus neoformans: a step in the evolution of sex chromosomes | Q31119504 | ||
| Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans | Q33753934 | ||
| Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis | Q33946946 | ||
| Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. | Q33959465 | ||
| Epidemiological evidence for dormant Cryptococcus neoformans infection | Q33962933 | ||
| Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans | Q33968048 | ||
| Protein O-mannosylation | Q64012589 | ||
| Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy | Q71744863 | ||
| Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans | Q72017965 | ||
| Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy | Q73522391 | ||
| Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network | Q33991281 | ||
| Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation | Q34054293 | ||
| Immunoregulation by capsular components of Cryptococcus neoformans. | Q34155052 | ||
| Capsule and melanin synthesis in Cryptococcus neoformans | Q34500174 | ||
| A yeast under cover: the capsule of Cryptococcus neoformans | Q35197202 | ||
| Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. | Q35225603 | ||
| The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. | Q35495143 | ||
| Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. | Q35567548 | ||
| Chronic cryptococcal meningitis: a new experimental model in rabbits | Q35863351 | ||
| Cryptococcus neoformans capsule biosynthesis and regulation | Q35902507 | ||
| The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies | Q36230201 | ||
| Induction of Capsule Growth inCryptococcus neoformansby Mammalian Serum and CO2 | Q36376167 | ||
| Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence | Q36657718 | ||
| The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter | Q36792831 | ||
| Three Neocallimastix patriciarum esterases associated with the degradation of complex polysaccharides are members of a new family of hydrolases. | Q36879474 | ||
| Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide | Q37017345 | ||
| Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. | Q37064239 | ||
| Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan | Q37421661 | ||
| Epidemiologic differences between the two varieties of Cryptococcus neoformans | Q39154213 | ||
| PCR-mediated generation of a gene disruption construct without the use of DNA ligase and plasmid vectors | Q39528384 | ||
| Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains | Q39746326 | ||
| Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA | Q39885245 | ||
| What makes Cryptococcus neoformans a pathogen? | Q41695186 | ||
| Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity | Q43612702 | ||
| Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. | Q43796047 | ||
| Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans | Q44078226 | ||
| Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption | Q47945426 | ||
| Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli | Q48066496 | ||
| An alpha-1,3-mannosyltransferase of Cryptococcus neoformans | Q48227152 | ||
| P433 | issue | 6 | |
| P921 | main subject | protein structure | Q735188 |
| capsular associated protein | Q62648308 | ||
| Capsule structure designer protein | Q62834693 | ||
| protein involved in gxm O-acetylation | Q62841465 | ||
| capsular associated protein | Q62842019 | ||
| capsule related protein | Q62845226 | ||
| capsular associated protein | Q62858177 | ||
| putative capsule structure designer protein | Q62907325 | ||
| putative capsule structure designer protein | Q62907329 | ||
| Capsule structure designer protein | Q62622536 | ||
| protein involved in gxm O-acetylation | Q62625758 | ||
| capsular associated protein | Q62625960 | ||
| capsular associated protein | Q62625962 | ||
| capsule related protein | Q62626925 | ||
| putative capsule structure designer protein | Q62629530 | ||
| P304 | page(s) | 1513-1524 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Eukaryotic Cell | Q5408685 |
| P1476 | title | Cas3p belongs to a seven-member family of capsule structure designer proteins | |
| P478 | volume | 3 |
| Q31109146 | A beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases. |
| Q36420681 | Aimless mutants of Cryptococcus neoformans: failure to disseminate |
| Q34720974 | CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans |
| Q34492638 | Characterizing the role of RNA silencing components in Cryptococcus neoformans |
| Q47408961 | Comparative Ecology of Capsular Exophiala Species Causing Disseminated Infection in Humans |
| Q34082194 | Comparative transcriptome analysis of the CO2 sensing pathway via differential expression of carbonic anhydrase in Cryptococcus neoformans |
| Q34093469 | Cross talk between the cell wall integrity and cyclic AMP/protein kinase A pathways in Cryptococcus neoformans |
| Q40842324 | Cryptococcus gattii Capsule Blocks Surface Recognition Required for Dendritic Cell Maturation Independent of Internalization and Antigen Processing. |
| Q27002687 | Cryptococcus gattii infections |
| Q33797765 | Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains |
| Q24533548 | Cryptococcus neoformans gene expression during murine macrophage infection |
| Q34005219 | Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis |
| Q41967903 | Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1 |
| Q35240882 | Distinct and redundant roles of exonucleases in Cryptococcus neoformans: implications for virulence and mating |
| Q33898678 | Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A |
| Q33894565 | How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans |
| Q91644850 | Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans |
| Q37220077 | Intron retention-dependent gene regulation in Cryptococcus neoformans |
| Q34961874 | Introns regulate gene expression in Cryptococcus neoformans in a Pab2p dependent pathway |
| Q33264398 | Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans |
| Q37685585 | Microevolution of Serial Clinical Isolates of Cryptococcus neoformans var. grubii and C. gattii |
| Q37393673 | Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii |
| Q35783648 | Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. |
| Q41870667 | Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans |
| Q41773485 | Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level |
| Q36742785 | Synthesis of cell envelope glycoproteins of Cryptococcus laurentii |
| Q37066510 | Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans |
| Q24619875 | The Cryptococcus neoformans capsule: a sword and a shield |
| Q37337879 | The capsule of the fungal pathogen Cryptococcus neoformans |
| Q37831988 | The role of the cell wall in fungal pathogenesis. |
| Q57793440 | Transcriptional Heterogeneity of VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways |
| Q33719196 | Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade |
| Q41368021 | UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans |
| Q52323839 | Unraveling synthesis of the cryptococcal cell wall and capsule. |
| Q37742176 | Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis |
| Q37402023 | Virulence in Cryptococcus species |
Search more.